We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$5.56B
AUM Growth
+$273M
Cap. Flow
+$119M
Cap. Flow %
2.13%
Top 10 Hldgs %
28.06%
Holding
379
New
20
Increased
141
Reduced
127
Closed
12

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$52.6M
2
LMT icon
Lockheed Martin
LMT
+$50.9M
3
SE
Spectra Energy Corp Wi
SE
+$38M
4
PAYX icon
Paychex
PAYX
+$27.7M
5
AAPL icon
Apple
AAPL
+$24.8M

Top Sells

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$37.7M
2
RTX icon
RTX Corp
RTX
+$32.6M
3
KMI icon
Kinder Morgan
KMI
+$30.9M
4
DLR icon
Digital Realty Trust
DLR
+$27.6M
5
NNN icon
NNN REIT
NNN
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 15.97%
2 Consumer Staples 15.67%
3 Healthcare 14.85%
4 Energy 12.26%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
301
Honeywell
HON
$76.7B
$319K 0.01%
4,278
-841
-16% -$62.4K
ANZ
302
DELISTED
AUSTRALIA & NW ZEAL ADS(RP5 SH
ANZ
$316K 0.01%
11,050
+2,990
+37% +$85.5K
WPC icon
303
W.P. Carey
WPC
$16.4B
$309K 0.01%
4,875
+510
+12% +$33.6K
CTG
304
DELISTED
Computer Task Group, Inc.
CTG
$306K 0.01%
+18,940
New +$371K
TSM icon
305
TSMC
TSM
$2.17T
$305K 0.01%
17,956
+541
+3% +$9.23K
C icon
306
Citigroup
C
$226B
$300K 0.01%
6,187
+162
+3% +$8.19K
FSP
307
Franklin Street Properties
FSP
$46.6M
$298K 0.01%
23,363
CVS icon
308
CVS Health
CVS
$124B
$296K 0.01%
5,220
+520
+11% +$31K
D icon
309
Dominion Energy
D
$59.2B
$293K 0.01%
4,690
NGLS
310
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$293K 0.01%
5,685
ASEI
311
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
$290K 0.01%
4,810
SI
312
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$289K 0.01%
2,395
EPIQ
313
DELISTED
EPIQ SYSTEMS INC
EPIQ
$286K 0.01%
21,685
-140
-0.6% -$1.82K
PEGA icon
314
Pegasystems
PEGA
$5.18B
$281K 0.01%
28,200
BP icon
315
BP
BP
$108B
$276K 0.01%
8,030
-2,623
-25% -$90K
TXT icon
316
Textron
TXT
$15.1B
$276K 0.01%
10,000
VEA icon
317
Vanguard FTSE Developed Markets ETF
VEA
$234B
$269K ﹤0.01%
6,795
+120
+2% +$4.57K
MJN
318
DELISTED
Mead Johnson Nutrition Company
MJN
$266K ﹤0.01%
3,585
PTR
319
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$251K ﹤0.01%
2,280
-75
-3% -$8.59K
AXP icon
320
American Express
AXP
$233B
$250K ﹤0.01%
3,307
+25
+0.8% +$1.88K
AFL icon
321
Aflac
AFL
$64.3B
$248K ﹤0.01%
8,016
OPEN
322
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
$246K ﹤0.01%
3,510
+135
+4% +$9.44K
NXGN
323
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$245K ﹤0.01%
11,288
MCRS
324
DELISTED
MICROS SYSTEMS INC
MCRS
$244K ﹤0.01%
4,885
-35
-0.7% -$1.7K
SRCL
325
DELISTED
Stericycle Inc
SRCL
$242K ﹤0.01%
2,100

Similar funds

Bahl & Gaynor's Q3 2013 Portfolio in Review

As of Q3 2013, Bahl & Gaynor held 379 positions worth $5.56B, up 5.2% from $5.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bahl & Gaynor's Q3 2013 filing shows 20 new, 141 increased, 127 reduced and 12 closed positions. Its largest new stake was iShares Core High Dividend ETF: 172,920 shares worth $2.29M. The largest sale was Scotiabank, an estimated $37.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Bahl & Gaynor's largest Q3 2013 buy was iShares Core High Dividend ETF: 172,920 shares worth $2.29M.
  • Bahl & Gaynor added most to Cullen/Frost Bankers in Q3 2013, an estimated $52.6M increase.
  • Bahl & Gaynor's biggest Q3 2013 reduction was Scotiabank, cutting an estimated $37.7M.
  • Bahl & Gaynor fully exited SM Energy in Q3 2013, selling an estimated $539K.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $5.56B portfolio in Q3 2013.
  • Bahl & Gaynor opened 20 new positions and closed 12 in Q3 2013.
  • Bahl & Gaynor's portfolio value rose 5.2% quarter-over-quarter to $5.56B.

Based on Bahl & Gaynor's 13F filing for Q3 2013, filed 13 Nov 2013.